Logo image of BSL.DE

BASLER AG (BSL.DE) Stock Fundamental Analysis

FRA:BSL - Deutsche Boerse Ag - DE0005102008 - Common Stock - Currency: EUR

13.34  +0.86 (+6.89%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BSL. BSL was compared to 51 industry peers in the Electronic Equipment, Instruments & Components industry. BSL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, BSL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BSL has reported negative net income.
In the past year BSL had a positive cash flow from operations.
In multiple years BSL reported negative net income over the last 5 years.
In the past 5 years BSL always reported a positive cash flow from operatings.
BSL.DE Yearly Net Income VS EBIT VS OCF VS FCFBSL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

The Return On Assets of BSL (-2.18%) is worse than 60.78% of its industry peers.
BSL has a Return On Equity of -3.94%. This is comparable to the rest of the industry: BSL outperforms 41.18% of its industry peers.
Industry RankSector Rank
ROA -2.18%
ROE -3.94%
ROIC N/A
ROA(3y)-1.08%
ROA(5y)2.8%
ROE(3y)-1.96%
ROE(5y)4.7%
ROIC(3y)N/A
ROIC(5y)N/A
BSL.DE Yearly ROA, ROE, ROICBSL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

BSL has a better Gross Margin (46.70%) than 64.71% of its industry peers.
In the last couple of years the Gross Margin of BSL has declined.
BSL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.66%
GM growth 5Y-2.2%
BSL.DE Yearly Profit, Operating, Gross MarginsBSL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

6

2. Health

2.1 Basic Checks

BSL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BSL has about the same amount of shares outstanding.
BSL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BSL has been reduced compared to a year ago.
BSL.DE Yearly Shares OutstandingBSL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BSL.DE Yearly Total Debt VS Total AssetsBSL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

BSL has an Altman-Z score of 3.98. This indicates that BSL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.98, BSL belongs to the top of the industry, outperforming 80.39% of the companies in the same industry.
The Debt to FCF ratio of BSL is 11.16, which is on the high side as it means it would take BSL, 11.16 years of fcf income to pay off all of its debts.
BSL's Debt to FCF ratio of 11.16 is in line compared to the rest of the industry. BSL outperforms 47.06% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that BSL is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.45, BSL is in line with its industry, outperforming 43.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 11.16
Altman-Z 3.98
ROIC/WACCN/A
WACC6.24%
BSL.DE Yearly LT Debt VS Equity VS FCFBSL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

BSL has a Current Ratio of 2.38. This indicates that BSL is financially healthy and has no problem in meeting its short term obligations.
BSL's Current ratio of 2.38 is fine compared to the rest of the industry. BSL outperforms 76.47% of its industry peers.
BSL has a Quick Ratio of 1.56. This is a normal value and indicates that BSL is financially healthy and should not expect problems in meeting its short term obligations.
BSL's Quick ratio of 1.56 is fine compared to the rest of the industry. BSL outperforms 74.51% of its industry peers.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 1.56
BSL.DE Yearly Current Assets VS Current LiabilitesBSL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

BSL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.39%, which is quite impressive.
Looking at the last year, BSL shows a small growth in Revenue. The Revenue has grown by 5.14% in the last year.
BSL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.74% yearly.
EPS 1Y (TTM)67.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%222.1%
Revenue 1Y (TTM)5.14%
Revenue growth 3Y-4.88%
Revenue growth 5Y2.74%
Sales Q2Q%33.52%

3.2 Future

The Earnings Per Share is expected to grow by 105.85% on average over the next years. This is a very strong growth
Based on estimates for the next years, BSL will show a quite strong growth in Revenue. The Revenue will grow by 13.24% on average per year.
EPS Next Y244.44%
EPS Next 2Y153.13%
EPS Next 3Y105.85%
EPS Next 5YN/A
Revenue Next Year7.63%
Revenue Next 2Y10.29%
Revenue Next 3Y11.45%
Revenue Next 5Y13.24%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BSL.DE Yearly Revenue VS EstimatesBSL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
BSL.DE Yearly EPS VS EstimatesBSL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BSL. In the last year negative earnings were reported.
BSL is valuated quite expensively with a Price/Forward Earnings ratio of 33.30.
BSL's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 35.28. BSL is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 33.3
BSL.DE Price Earnings VS Forward Price EarningsBSL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BSL is valued a bit more expensive than the industry average as 60.78% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, BSL is valued a bit more expensive than 60.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 67.98
EV/EBITDA 23.14
BSL.DE Per share dataBSL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

BSL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BSL's earnings are expected to grow with 105.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y153.13%
EPS Next 3Y105.85%

2

5. Dividend

5.1 Amount

BSL has a Yearly Dividend Yield of 1.52%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.92, BSL has a dividend in line with its industry peers.
BSL's Dividend Yield is slightly below the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.52%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BSL.DE Yearly Dividends per shareBSL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y153.13%
EPS Next 3Y105.85%
BSL.DE Yearly Income VS Free CF VS DividendBSL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

BASLER AG

FRA:BSL (8/8/2025, 1:52:55 PM)

13.34

+0.86 (+6.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-08 2025-05-08
Earnings (Next)08-07 2025-08-07
Inst Owners24.18%
Inst Owner ChangeN/A
Ins Owners6.63%
Ins Owner ChangeN/A
Market Cap420.21M
Analysts80
Price Target15.45 (15.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.52%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.48%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.97%
Revenue NY rev (3m)3.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 33.3
P/S 2.11
P/FCF 67.98
P/OCF 25.94
P/B 3.26
P/tB 10.98
EV/EBITDA 23.14
EPS(TTM)-0.17
EYN/A
EPS(NY)0.4
Fwd EY3%
FCF(TTM)0.2
FCFY1.47%
OCF(TTM)0.51
OCFY3.85%
SpS6.34
BVpS4.09
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.18%
ROE -3.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.7%
FCFM 3.1%
ROA(3y)-1.08%
ROA(5y)2.8%
ROE(3y)-1.96%
ROE(5y)4.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.66%
GM growth 5Y-2.2%
F-Score6
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 11.16
Debt/EBITDA 3.05
Cap/Depr 52.06%
Cap/Sales 5.02%
Interest Coverage N/A
Cash Conversion 84.72%
Profit Quality N/A
Current Ratio 2.38
Quick Ratio 1.56
Altman-Z 3.98
F-Score6
WACC6.24%
ROIC/WACCN/A
Cap/Depr(3y)94.94%
Cap/Depr(5y)97.08%
Cap/Sales(3y)7.69%
Cap/Sales(5y)7.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%222.1%
EPS Next Y244.44%
EPS Next 2Y153.13%
EPS Next 3Y105.85%
EPS Next 5YN/A
Revenue 1Y (TTM)5.14%
Revenue growth 3Y-4.88%
Revenue growth 5Y2.74%
Sales Q2Q%33.52%
Revenue Next Year7.63%
Revenue Next 2Y10.29%
Revenue Next 3Y11.45%
Revenue Next 5Y13.24%
EBIT growth 1Y99.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year373.81%
EBIT Next 3Y96.72%
EBIT Next 5YN/A
FCF growth 1Y148.05%
FCF growth 3Y-20.46%
FCF growth 5YN/A
OCF growth 1Y13.77%
OCF growth 3Y-16.7%
OCF growth 5Y-9.96%